Related references
Note: Only part of the references are listed.A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b
Taizhen Liang et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Getting the Kill into Shock and Kill: Strategies to Eliminate Latent HIV
Youry Kim et al.
CELL HOST & MICROBE (2018)
Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression
Thomas D. Zaikos et al.
JOURNAL OF VIROLOGY (2018)
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
Donn J. Colby et al.
NATURE MEDICINE (2018)
Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes
Marco A. Moro-Garcia et al.
FRONTIERS IN IMMUNOLOGY (2018)
Post-translational Modification-Based Regulation of HIV Replication
Lin Chen et al.
FRONTIERS IN MICROBIOLOGY (2018)
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes
Ryan J. Conrad et al.
MOLECULAR CELL (2017)
The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells
Hanyu Pan et al.
ONCOTARGET (2017)
A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoir
Axel Fun et al.
SCIENTIFIC REPORTS (2017)
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo et al.
NATURE (2016)
Defective proviruses rapidly accumulate during acute HIV-1 infection
Katherine M. Bruner et al.
NATURE MEDICINE (2016)
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases
Kaustav Das Gupta et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Histone Deacetylase Inhibitor Romidepsin Inhibits De Novo HIV-1 Infections
Kasper L. Jonsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Amanda M. Crooks et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation
Maria-Soledad Valera et al.
RETROVIROLOGY (2015)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Sogaard et al.
PLOS PATHOGENS (2015)
HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat
Nancy M. Archin et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
Courtney V. Fletcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy
Anthony R. Cillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Long-lived reservoirs of HIV-1
Thomas D. Zaikos et al.
TRENDS IN MICROBIOLOGY (2014)
Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing
Datsen George Wei et al.
PLOS PATHOGENS (2014)
An Upstream YY1 Binding Site on the HIV-1 LTR Contributes to Latent Infection
Wendy Bernhard et al.
PLOS ONE (2013)
Reactivation of latent HIV by histone deacetylase inhibitors
Kotaro Shirakawa et al.
TRENDS IN MICROBIOLOGY (2013)
Comparison of HDAC inhibitors in clinical development Effect on HIV production in latently infected cells and T-cell activation
Thomas Aagaard Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Susanne Eriksson et al.
PLOS PATHOGENS (2013)
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study
J. P. Routy et al.
HIV MEDICINE (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy (vol 487, pg 482, 2012)
N. M. Archin et al.
NATURE (2012)
Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs
Lisa N. McKernan et al.
ADVANCES IN VIROLOGY (2012)
Regulation of Tat Acetylation and Transactivation Activity by the Microtubule-associated Deacetylase HDAC6
Lihong Huo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
ChemMine tools: an online service for analyzing and clustering small molecules
Tyler W. H. Backman et al.
NUCLEIC ACIDS RESEARCH (2011)
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
Rajeev Mehla et al.
PLOS ONE (2010)
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Nancie M. Archin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression
Kara S. Keedy et al.
JOURNAL OF VIROLOGY (2009)
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Nathalie Sagot-Lerolle et al.
AIDS (2008)
Suv39H1 and HP1γ are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency
Isaure du Chene et al.
EMBO JOURNAL (2007)
Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing
Celine Marban et al.
EMBO JOURNAL (2007)
Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection
A Valenzuela-Fernández et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter
M Lusic et al.
EMBO JOURNAL (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)